Correction: Damiański et al. Pathway to Remission in Severe Asthma: Clinical Effectiveness and Key Predictors of Success with Benralizumab Therapy: A Real-Life Study. Biomedicines 2025, 13, 887

Error in Figure

In the original publication [1], there was a mistake in Figure 1b as published. In the section of the figure corresponding to ACQ < 1.5, the values are currently presented incorrectly. According to the text above the figure, the correct values should be “achieved: 33%”, “not achieved: 67%”.

The corrected Figure 1b appears below:

Figure 1. Panel (a) presents the proportion of patients meeting the criteria for clinical remission, clinical response, or classified as non-responders (%). Panel (b) illustrates the individual components of the disease remission criteria after one year of BENRA therapy (expressed as %).

Figure 1. Panel (a) presents the proportion of patients meeting the criteria for clinical remission, clinical response, or classified as non-responders (%). Panel (b) illustrates the individual components of the disease remission criteria after one year of BENRA therapy (expressed as %).

The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.